IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Sabby Management, LLC

Q1 2026 Holdings

Filed 2026-05-15 | 28 holdings | $45.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Spdr S&P 500 ETFPutETF78462F953$29.1M44764.5%
Ishares TRPutETF464287955$7.4M30016.5%
Spdr S&P 500 ETF(SPY)ETF78462F103$1.8M2,7343.9%
Gevo IncPutCOM374396956$1.4M5,2523.2%
Abivax SACallADS00370M903$857.4K771.9%
Alphaton Capital CorpSHSG7185A136$654.8K2,072,1031.5%
Briacell Therapeutics Corp(BCTXL)*W107930125$392.1K380,6860.9%
Senestech Inc(SNES)COM81720R604$358.4K218,5330.8%
BIG Tree Cloud Hldgs LTDCL AG1263B132$337.1K137,6110.7%
Zevra Therapeutics IncPutCOM488445956$316.9K3400.7%
Briacell Therapeutics Corp(BCTX)COM107930307$309.7K73,9150.7%
Sidus Space IncPutCOM826165951$243.4K1,0490.5%
Token CAT LTDADS89856T401$241.7K23,2390.5%
POP Culture Group Co LTDSHSG71700119$201.1K664,4490.4%
Moleculin Biotech Inc(MBRX)COM60855D408$171.8K75,0210.4%
Biodexa Pharmaceuticals PLC(BDRX)ADS59564R880$159.1K257,4720.4%
Arcadia Biosciences Inc(RKDA)COM039014303$158.1K114,5540.4%
TRX Gold Corp(TRX)COM87283P109$150.0K100,0000.3%
Inmed Pharmaceuticals Inc(INM)COM457637700$142.0K220,2600.3%
CAN Fite Biofarma LTDADR13471N409$131.9K42,5590.3%
China SXT Pharmaceuticals Inc(SXTC)CL AG2161P165$131.3K78,1700.3%
Revelation Biosciences Inc(REVB)COM76135L804$119.3K99,4320.3%
Calidi Biotherapeutics Inc(CLDI)COM320703408$103.9K434,9030.2%
Bluejay Diagnostics Inc(BJDX)COM095633608$52.9K28,7260.1%
Lyra Therapeutics Inc(LYRA)COM55234L204$51.1K104,0590.1%
Tempest Therapeutics Inc(TPST)COM87978U207$29.3K17,8560.1%
Briacell Therapeutics Corp(BCTXZ)*W107930117$28.9K206,7530.1%
BNB Plus Corp(BNBX)COM03815U607$8.7K13,5410.0%